Literature DB >> 20391013

An ELISA for quantification of T84.66, a monoclonal anti-CEA antibody, in mouse plasma.

Shweta R Urva1, Victor C Yang, Joseph P Balthasar.   

Abstract

T84.66 is a monoclonal antibody with high affinity and specificity for tumor-associated carcinoembryonic antigen (CEA). In this work, we have developed an enzyme linked immunosorbent assay to determine T84.66 concentrations in mouse plasma. The assay was validated with respect to precision and accuracy by evaluating the recovery of T84.66 from mouse plasma. The working range of the assay is 25-200 ng/mL, and the limit of quantification is 2.5 microg/mL. Intra-assay recoveries ranged from 90.6 to 97.4%, and intra-assay precision reported as the percent coefficient of variation (CV%), ranged from 4.58 to 12.6%. Inter-assay recoveries were between 92.6 to 98.1% and the CV% ranged from 4.9-6.5%. The assay was tested for possible interference from soluble CEA. Soluble CEA, at concentrations up to 5 ng/mL, did not influence the recovery of T84.66. The assay was applied to study the pharmacokinetics of T84.66 in athymic Fox(nu) mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20391013     DOI: 10.1080/15321810903404772

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  3 in total

1.  Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis.

Authors:  Xiaotao Duan; Lipeng Dai; Shang-Chiung Chen; Joseph P Balthasar; Jun Qu
Journal:  J Chromatogr A       Date:  2012-06-21       Impact factor: 4.759

Review 2.  Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.

Authors:  Bo An; Ming Zhang; Jun Qu
Journal:  Drug Metab Dispos       Date:  2014-09-02       Impact factor: 3.922

3.  Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Cheol Moon; Joseph P Balthasar; Victor C Yang
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.